Navigation Links
Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
Date:3/12/2013

SAN DIEGO, March 12, 2013 /PRNewswire/ -- CA BOTANA International, Inc., StemNext LLC  and Molecular Botanicals LLC are pleased to announce an innovative research collaboration focused on the design, development, and manufacturing of a series of state-of-the-art cosmeceutical products aimed at preventing aging and the reversal of the effects of aging on the skin.

(Logo: http://photos.prnewswire.com/prnh/20130312/SF74940LOGO)

"With CA BOTANA's decades of experience developing and implementing novel cosmetics formulation techniques, and StemNext's cutting-edge biotechnology expertise, we look forward to creating the highest quality skin care and hair loss prevention products," said Dr. Dieter Kuster of Molecular Botanicals LLC.

Stated Dr. Daniel D. Holsworth , CEO of StemNext LLC, "CA BOTANA has a wide range of proprietary cosmetics formulations and top notch manufacturing facilities. We're excited to apply our next-generation methods in Peptide discovery, compound synthesis, and plant derived stem cell biology to the development of this new series of cosmeceutical products."

Prho-Life Style Enhancing Serum, a peptide-based formulation designed to reverse the effects of aging on the skin, is the first in a series of new products from the CA BOTANA/StemNext/Molecular Botanicals collaboration. Prho-LE Serum stimulates a key skin stem cell pathway in the epidermis, and is currently undergoing human clinical trials in Germany. It will be marketed under the Dr. Schwab Clinical Series.

About CA BOTANA International
CA BOTANA , headquartered in San Diego, CA, has developed and manufactured skin care products for over 40 years, studying the effects of sea extracts, plants, herbs and vitamins, and integrating breakthrough discoveries with the latest skin care technology.  For more information about CA BOTANA, visit the website at www.ca-botana.com, call 858-450-1717, or email us at healthyskin@ca-botana.com.

About StemNext LLC
Based in San Diego, CA, StemNext, LLC is an upstart biotech firm focused on rapid, efficient drug discovery and development, and the application of stem cell biology expertise to the cosmetics, pharmaceutical, and biotechnology industries. The StemNext team has 20+ years experience developing pharmaceuticals in multiple therapeutic areas.

About Molecular Botanicals LLC
Based in San Diego, CA, Molecular Botanicals LLC is a cosmetic science, formulation and research company who develops leading peptide technology and innovative ingredients and raw materials for the medical, cosmetic and OTC field.


'/>"/>
SOURCE CA BOTANA International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Johns Hopkins University and Mt. Sinai Hospital of Toronto Honored For Innovative Use of Health Information and Technology to Improve Patient Care
2. Next-Generation Drug-Device Combinations Provide Innovative Delivery Methods for the Growing Biologics Market
3. Healthcare Innovation World Cup: Innovative Ideen zur Bekämpfung von Diabetes gesucht
4. Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
7. Unilife to Showcase Broad Portfolio of Innovative, Differentiated Injectable Drug Delivery Systems at Pharmapack Europe
8. QualiMed Innovative Medizinprodukte GmbH, Based in Winsen Germany has Received Notice of CE Approval for its Line of Peripheral Balloons for the Treatment of Peripheral Vascular Obstructions
9. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
10. Stratasys Objet Eden260V Wins "2013 Product Award - Top Innovative Equipment" from The Dental Advisor Magazine
11. BioElectronics Announces South Korean Patent Allowance for its Innovative OTC Pain Relief Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
(Date:2/4/2016)... , Feb. 4, 2016  AMRI (NASDAQ:  AMRI) today announced ... Pfizer Inc. and President of Pfizer Global Supply, has been ... February 4, 2016. In addition, the Company announced that Mr. ... audit committee since 2010, has retired from the AMRI Board ... to his other business ventures.  William S. ...
(Date:2/4/2016)... -- --> --> ... Automated External Defibrillator (AED) Market by Product (Semi-Automated External ... Hospitals, Homecare & Nursing Homes) - Forecast to 2019", ... and segments the concerned market with an analysis and ... grow to about $367.0 million by 2019, at a ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... ... stage for new clinical and scientific initiatives have all marked the last 12 ... appointed President and CEO of the nation’s oldest cancer center, Candace S. Johnson, ...
(Date:2/5/2016)... Rosa, CA (PRWEB) , ... February 05, 2016 ... ... pleased to announce the addition of micro-needling services in their Napa Valley office. ... The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... independent PROSHRED franchises from across the country gathered at the La Valencia Hotel ... top performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking ...
(Date:2/5/2016)... ... , ... Give To Cure today announced that it is working ... To Cure’s campaign that is crowdfunding clinical trials to help find cures faster for ... a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. ...
Breaking Medicine News(10 mins):